SGA analysis provided us with an opportunity to characterize the interrelationships between the various components of the SUMO pathway. The siz1∆ and siz2∆ screens generated a relatively small number of synthetic lethal/sick interactions; only 27 and 22, respectively, with 20% overlap (Table S2 ). To test for Siz1p and Siz2p functional redundancy, we performed SGA analysis using siz1∆ siz2∆ as a query strain. The siz1∆ siz2∆ E3 double deletion screen produced 239 synthetic lethal/sick interactions, suggesting that under normal laboratory growth conditions Siz1p and Siz2p are largely redundant; i.e. the loss of either SUMO ligase can be functionally substituted by the other. We cannot rule out the possibility that some of these genetic interactions could be caused by increased 2 µm plasmid copy number, a phenomenon previously demonstrated to occur in the siz1∆siz2∆ strain (Chen et al., 2005) . However, a comparison of the siz1∆ siz2∆ synthetic lethal/sick dataset with SUMO mutants that tend to lose the 2 µm plasmid (ubc9-2 and ulp1-333 SGG ) revealed an 80% overlap. Hence, we propose that the siz1∆ siz2∆ genetic interaction network largely maps genes that are required for functional buffering of alterations in the level of sumoylation in the cell, and not those related to increased 2 µm plasmid levels.
SGA analysis of a strain expressing a point mutant of the third known SUMO E3 ligase mms21-sp (Reindle et al., 2006; Zhao and Blobel, 2005) produced 281 hits (Table S2 ). The mms21-sp screen showed only a 33% overlap with the siz1∆ siz2∆ screen, indicating that a large group of genes rely specifically upon Mms21p activity that cannot be rescued by the Siz1p or Siz2p ligases. These data are consistent with the recent observation that both of the double mutants siz1∆ mms21-sp and siz2∆ mms21-sp grow more slowly then either the siz1∆siz2∆ double mutant or the mms21-sp single mutant, and that the siz1∆ siz2∆ mms21-sp triple mutant is inviable (Reindle et al., 2006) .
As expected, the correlation between the E3 screens and the ubc9-2 (E2) screen was high; 77% for siz1∆ siz2∆ and 76% for mms21-sp (Table S2 ). The genetic interactions not shared with ubc9-2 may be explained by an incomplete loss of function conferred by the temperature sensitive ubc9-2 allele. Interestingly, however, the ubc9-2 screen also yielded 13% unique genetic interactions (not overlapping with any of the known E3 ligases) that could represent critical interactions with one or more unknown SUMO E3 ligases, or cases in which Ubc9p can directly catalyze SUMO conjugation without the involvement of an E3 ligase. Consistent with this idea, in vitro sumoylation reactions do not require an E3 ligase , and crystallographic studies have demonstrated that Ubc9p can interact directly with target proteins to catalyze SUMO conjugation (Yunus and Lima, 2005) .
We expected that our genetic interaction data would reflect the highly dynamic nature of sumoylation, in which SUMO conjugation is balanced by its removal (deconjugation) from target proteins. Indeed, the correlation between the two SUMO protease screens (ulp1-333 SGG and ulp2-DAmP) and the SUMO E3 ligase screens was 81% for siz1∆ siz2∆ and 66% for mms21-sp (Table   S2 ). The smt3-331 mutant screen also displayed a high degree (70%) of overlap with the SUMO proteases, and an 80% overlap with the SUMO ligase screens. Intriguingly, the hits unique to smt3-331 could represent cases in which SUMO function is fulfilled through a non-covalent interaction with SIM bearing proteins (Hecker et al., 2006) .
SUMO is translated as an inactive pro-protein that must be processed to the mature form by Ulp1p before it can be conjugated to target proteins . In order to specifically identify genetic interactions with Ulp1p SUMO deconjugation activity, we constructed the ulp1-333 SGG strain, which expresses both endogenous SMT3 and a mature, pre-processed GFP-SUMO protein, and displays elevated levels of proteins sumoylation (Makhnevych et al., 2007) . The ulp2-DAmP strain was utilized in our screen because complete ULP2 deletion resulted in severe sporulation defects, and was therefore not suitable for SGA analysis. The ulp1-333 SGG strain displayed genetic interactions with 332 genes, while the ulp2-DAmP strain yielded only 63 such interactions (Table S2 ). The relatively low number of interactions in the ulp2-DAmP screen may be explained either by the nature of the mutation or by the limitations of the SGA approach in studying meiosis, a process in which Ulp2p function seems to be critical (Li and Hochstrasser, 2000) . Most of the ulp2-DAmP-specific genetic interactions (78%) were also observed in our SUMO ligase screens. The ulp1-333 SGG and ulp2-DAmP screens shared only 28 genetic interactions, 27 of which were also shared with one or more of the SUMO ligase screens. These data strongly support the notion that Ulp1p and Ulp2p act on distinct substrates, and are not generally redundant (Li and Hochstrasser, 2000) .
ulp1 mutant strains share many phenotypes with mutants of the SUMO conjugation machinery (Panse et al., 2006; Chen et al., 2005) . The explanation previously proposed for this overlap was the defect in SUMO pro-protein processing in ulp1 mutants, and a consequent lack of SUMO conjugation. Our data suggest instead that Ulp1p deconjugation activity can account for many of the previously reported ulp1 mutant phenotypes; mature SUMO was not limiting in the ulp1-333 SGG SGA query strain, and we observed a significant correlation between the ubc9-2 and ulp1-333 SGG screens (Table S2) .
Notwithstanding the similarity in genetic profiles, some interesting differences concerning the E3 ligases was noted. For example, the siz1∆ siz2∆ mutant depends for survival upon an intact homologous recombination (HR) DNA repair pathway, and genes involved in the establishment of sister chromatid cohesion during DNA replication and replication fork maintenance (CTF18, CTF8, MRC1 and CTF4), whereas mms21-sp did not yield strong interactions with this group of genes (Table S2) . We also uncovered unique genetic interactions for ulp1-333 SGG with genes involved in chromosome segregation, consisting of kinetochore components (CBF2/NDC10, CTF3, MCM22) and members of the COMA complex (CTF19, OKP1, MCM21, DSN1), which bridge kinetochore subunits with centromeric DNA. These results are in good agreement with the recent finding that several kinetochore proteins are sumoylated in yeast, and that SUMO conjugation and deconjugation seem to play distinct roles in the modulation of kinetochore function. Specifically, Cbf2p/Ndc10p and Bir1p are desumoylated in response to nocodazole treatment (Montpetit et al., 2006) , suggesting that removal of SUMO could signal that metaphase spindles are disrupted.
Interestingly, the SGA analysis also highlighted a sub-network of 294 genes ( Figure 2 , middle section; representing 55% of the hits in our analysis) that produced synthetic lethal/sick interactions with both SUMO ligases and proteases: i.e. mutation of any single gene in this large group simultaneously renders the cell sensitive to either a deficiency or an excess of sumoylation.
This sub-network includes many genes (NUP60, NUP133, ESC1, SLX5, HEX3 RPT6/CIM3 and UBC4) previously demonstrated to modulate steady-state levels of sumoylation in the cell (Lewis et al., 2007; Uzunova et al., 2007; Figure 2) . We therefore anticipate that this sub-network is enriched with genes that function to monitor and regulate steady-state sumoylation levels. It would thus be of great interest to further characterize these proteins, in order to better understand their relationship with the SUMO pathway.
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SUPPLEMENTAL EXPERIMENTAL PROCEDURES

Yeast strains and plasmids
Yeast strains used in this study were derived from BY4741 (MATα) or BY4743 (MATa/α) (Wykoff and O'Shea, 2005) , which consists of an N-terminal green fluorescent protein (GFP) moiety fused to a processed form of the SUMO protein, was introduced into the LEU2 locus of the ulp1-333 strain (Li and Hochstrasser, 1999) . The resultant strain (ulp1-333 SGG ) expresses both endogenous Smt3p and a mature, pre-processed GFP-Smt3-∆C protein, and displays elevated levels of sumoylation (Makhnevych et al., 2007) .
Strain
c Y11666 the ULP2 natural 3' UTR was disrupted by PCR-based homologous recombination by insertion of an NATR cassette creating ulp2-DAmP (decreased abundance by mRNA perturbation) mutant (Muhlrad and Parker, 1999) .
Plasmids and Proteins
pAG416GAL-GFP-SPT23 (p5571) and pAG416GAL-GFP-MGA2 (p5572) plasmids were constructed using corresponding ORFs obtained from the Yeast FLEXGene collection (Hu et al., 2007) . Both ORFs were first subcloned into Gateway(R) donor vector pDONR201, then subcloned into N-terminal GFP fusion expression vector pAG416GAL-GFP following a published protocol (Alberti et al., 2007) . pGST-RAD9 and pHF-SMT3 were gifts of R. Sopko and E. Johnson, respectively.
pGEX-6P-1-Smt3-x3, encoding an N-terminal GST moiety fused to a trimeric tandem repeat of the SMT3 coding region (1-294) was constructed using standard recombinant cloning techniques, and verified by DNA sequencing. pGEX-6P-1-Smt3-x3 protein was expressed in BL21
E.coli induced with 2 mM isopropyl-β-D-1-thiogalactopyranoside at 37°C for 3 hr. Proteins were purified using MagneGST™ glutathione particles (Promega), according to manufacturer's instructions.
SUMO affinity purification
All steps were performed at 4 o C. 1 ml of yeast lysate (containing ~25 mg protein) was pre-cleared with 500 μg of recombinant purified GST pre-bound to magnetic glutathione beads, incubated endover-end for 3 hrs. Beads were removed and washed three times with PBS, then placed directly into Laemmli buffer. This purification served as a negative control. The GST-cleared lysate was combined with 500 μg recombinant purified GST-Smt3-x3 (representing 25 µM SUMO in solution)
pre-bound to magnetic glutathione beads, and incubated end-over-end for another 3 hr. Beads were washed 3x with PBS and 2x with cleavage buffer, after which Smt3p interacting partners were eluted via overnight treatment with PreScission™ Protease (GE Healthcare), directed at a cleavage site located between the GST moiety and the Smt3-x3 region. Eluate (containing the cleaved SUMO protein and interactors) was removed, and beads were washed twice with 500 μl cleavage buffer. Eluate and washes were combined and concentrated using a 3 kDa nominal molecular mass cutoff centrifugal filter unit (Microcon®, Millipore). Retentant proteins were resuspended in 4x
XT sample buffer (Bio-Rad). GST-interacting partners (negative control) were eluted directly from glutathione beads by the addition of 2x XT sample buffer. Samples were separated via 4-12% BisTris Criterion XT SDS-PAGE with XT-MES buffer (BioRad).
Gels were stained with coomassie brilliant blue, and each lane cut into ten roughly equal sections to decrease sample complexity. Each gel section was sliced into 3 mm 2 pieces, and subjected to three cycles of dehydration (acetonitrile 20 min) and rehydration (deionized water 20 min). Following a final dehydration step (20 min SpeedVac), gel pieces were rehydrated in 50 mM ammonium bicarbonate [pH 8.3 ] containing 1 μg TPCK trypsin (Promega), and incubated at 37°C for 16 hr.
Peptides were extracted from the gel pieces using three dehydration/rehydration steps (as above).
Eluted peptides were pooled, lyophilized and resuspended in 5% (v/v) acetonitrile in 0.1% (v/v) formic acid for MS analysis.
Mass spectrometry and data analysis
Digested peptide mixtures were subjected to LC-MS/MS performed using a linear ion trap mass spectrometer (LTQ; Thermo Fisher Scientific) coupled to an Agilent 1100 nano-HPLC system (Agilent Technologies). Analytical columns were made from 10 cm fused silica capillaries (75 μm inner diameter; InnovaQuartz, Phoenix, AZ), packed in-house with C 18 -coated particles (Michrom Bioresources, Auburn, CA). Peptides were injected onto a 2 cm (100 μm inner diameter) in-house packed C 18 pre-column at a flow rate of 10 μl/min. Chromatographic separation was achieved using a 100 min gradient, from 100% buffer A (5% acetonitrile with 0.1% formic acid) to 40% buffer B (95% acetonitrile with 0.1% formic acid), followed by a 20 min isocratic phase at 100% buffer B. The mass spectrometer was operated in data-dependent acquisition mode: following a survey (400-1800 m/z) MS scan, the six most intense ions were chosen for fragmentation using collision-induced dissociation (CID). Target ions for which three previous CID scans had been collected (within 60 sec), were dynamically excluded for 60 sec.
Proteins were identified using automated database searching using the X!Tandom/K-score algorithm (Craig and Beavis, 2004; Keller et al., 2005; MacLean et al., 2006) and the SGD yeast protein database. Search parameters specified a parent MS tolerance of +3.0 Da and -0.5 Da, and an MS/MS tolerance of 0.4 Da, with up to two missed cleavages for trypsin. Oxidation of methionine was allowed as a variable modification. Statistical validation of the results was performed using Peptide Prophet and Protein Prophet (Keller et al., 2002; Nesvizhskii et al., 2003) as part of the trans-proteomic pipeline (Keller et al., 2005) . For each search, the Protein Prophet probability at a 3% calculated error rate was used as a cutoff value. Identifications from both control (GST) and SUMO experiments were compiled, and proteins identified in the control experiment were subtracted from the SUMO identifications. GST (negative control) and SUMOinteractor affinity purifications were conducted four times each, comprising ~100 MS runs.
The most abundant SUMO-specific binding protein identified in our screen was a component of the heterodimeric SUMO E1, Uba2p. Also identified as SUMO interactors were the second E1 component, Aos1p, the SUMO E2 protein Ubc9p, and a number of previously identified SUMO conjugates, involved in a wide range of cellular processes.
